Software / Biotech / Photonic AI Infrastructure
Bending Spoons, OMass, Salience Labs — $330M from Berkshire, $310M for biotech and $125M for photonic chips — Daily News October 15, 2026
01:42
•
15/10/2026
Listen on Spotify🇮🇹 Podcast in Italian
About this episode
Berkshire Hathaway announces a $330 million private placement in Bending Spoons, OMass Therapeutics raises $310 million, and Salience Labs closes a $125 million Series B.
Europe's most interesting startup stories. Every week.
No spam. Unsubscribe anytime.
Main news
Startups mentioned
Bending Spoons
Milan-based software group founded in Copenhagen in 2013 and listed on Nasdaq (BSP) since 1 July 2026 at $29 a share. No longer a private unicorn.
OMass Therapeutics
An Oxford biotech developing small-molecule medicines using structural mass spectrometry to study complex protein targets in their native environment.
Salience Labs
An Oxford startup developing integrated photonic switches connecting GPUs and racks in data centres built for artificial-intelligence workloads.
Listen to the episode
Listen on Spotify🇮🇹 Podcast in Italian